GlaxoSmithKline (GSK) has announced a significant leadership transition, appointing Luke Miels as the new Chief Executive Officer, effective January 1, 2024. Miels, who has served as...
GSK has announced a leadership transition, appointing Luke Miels as the company’s new Chief Executive Officer, effective January 1, 2024. Miels will succeed Emma Walmsley, who...